Sensory-motor axonal peripheral neuropathy in an advanced breast cancer patient treated with ixabepilone

Ixabepilone is a novel microtubule-stabilising agent used as monotherapy or in combination with capecitabine to treat taxane- and anthracycline-refractory breast cancer.

We report the case of a patient who experienced an unusual motor neuropathy after the first cycle. This is a very uncommon secondary effect, but it must be taken into account as a possible complication of treatment with ixabepilone.

CITATION  Clin Transl Oncol. 2009 Nov;11(11):765-7